Cel-Sci Statistics
NYSE: CVMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.21-0.26 (-17.69%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cel-Sci by the numbers
Cel-Sci has a market capitalization of $21.3 million based on 17.59M shares outstanding. With trailing EPS of $-1.69, Cel-Sci is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.9% below its 50-day average and 45.0% below its 200-day average.
Average daily trading volume is 231.46K shares, or about $280,069 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CVM valuation vs. peer median
| Metric | CVM | Peer median | Difference |
|---|---|---|---|
| Market cap | $21.28M | $24.77M | -14% |
| Avg. volume | 231.46K | 124.11K | +86% |
Peer median across 8 companies: MGX, EVAX, SAEN, PTHS, INMB, LONA, EXOZ, ESLA.
Valuation
- Market cap
- $21.28M
- EPS (TTM)
- $-1.69
- Shares outstanding
- 17.59M
Price and trading
- Previous close
- 1.47
- Open
- 1.54
- Day range
- 1.19 – 1.59
- 52-week range
- 0.89 – 7.80
- 52-week change
- -80.67%
- Beta
- —
- Volume
- 879.70K
- Average volume
- 231.46K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Feb 12, 2026
Additional statistics
- Market Cap
- 21.28M
- Forward Pe
- -0.19
- Eps
- -1.69
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.80
- Week52 Low
- 0.89
- Avg Volume
- 231.46K
- Shares Outstanding
- 17.59M
- Ma50
- 1.66
- Ma200
- 2.20
- Earnings Date
- Feb 12, 2026
- Pct From52w High
- -84.49%
- Pct From52w Low
- 35.96%